Circular No. 12/2026/TT-BYT on the List of congenital diseases requiring prenatal and neonatal screening

Category: Circular
  • Validity
  • Content
  • Diagram
  • Download

Validity Status

Circular No. 12/2026/TT-BYT on the List of congenital diseases requiring prenatal and neonatal screening takes effect from 01/07/2026.
Effective from: 01/07/2026
Effective to: No expiration
Status: In effect

Content Details

MINISTRY OF HEALTH OF VIETNAM
——–

THE SOCIALIST REPUBLIC OF VIETNAM
Independence – Freedom – Happiness
—————

No. 12/2026/TT-BYT

Hanoi, May 15, 2026

 

CIRCULAR

ON THE LIST OF CONGENITAL DISEASES REQUIRING PRENATAL AND NEONATAL SCREENING

Pursuant to the Law on Population No. 113/2025/QH15;

Pursuant to the Law on Medical Examination and Treatment No. 15/2023/QH15;

Pursuant to Decree No. 42/2025/ND-CP dated February 27, 2025 of the Government on functions, tasks, powers and organizational structure of the Ministry of Health of Vietnam;

At the request of the Director General of the Vietnam Population Authority;

The Minister of Health promulgates the Circular on the List of congenital diseases requiring prenatal and neonatal screening.

Article 1. The List of congenital diseases recommended for prenatal and neonatal screening

The List of congenital diseases recommended for prenatal screening prescribed in Appendix I and the List of congenital diseases recommended for neonatal screening prescribed in Appendix II are attached to this Circular to elaborate clause 1, Article 21 of the Law on Population.

Article 2. Definitions

Congenital disease means structural or functional abnormalities (including metabolic disorders) that occur during the fetal period and have adverse effects on an individual’s health.

Article 3. Principles for development of the List of congenital diseases

The selection of congenital diseases for the List shall comply with the following principles:

1. Prevalence and disease burden:

a) Congenital diseases with a high prevalence or high frequency of gene mutations in the population, or those causing severe consequences for a child’s health, physical condition and intellectual development;

b) Congenital diseases with high mortality rates in children or those causing lifelong disabilities and affecting the quality of the population.

2. Screening and diagnostic capacity:

a) There are appropriate, safe and easy-to-implement screening methods;

b) There are diagnostic methods or techniques to confirm the disease after screening results are obtained.

3. Feasibility and socio-economic effectiveness:

a) Compatible with the capacity of Vietnam’s healthcare system in terms of equipment and human resources;

b) Screening costs are appropriate for the financial capacity of the population, the state budget, or health insurance;

c) The socio-economic benefits gained from early detection, treatment and intervention are greater than those obtained from late detection.

Article 4. Effect

This Circular comes into force from July 01, 2026.

Article 5. Implementation

1. The Vietnam Population Authority shall:

a) Take charge and cooperate with relevant units in providing guidelines, directing and inspecting the implementation of this Circular nationwide;

b) Every two years, or when there are professional, technical or legal requirements, the Vietnam Population Authority shall take charge in reviewing and proposing amendments to the List attached to this Circular;

c) Take charge and cooperate with the Administration of Maternal and Children’s Affairs, the Department of Medical Service Administration and relevant units in developing, updating and proposing competent authorities for issuance of technical procedures and guidelines on prenatal and neonatal screening, diagnosis and treatment in accordance with the Law on Medical Examination and Treatment;

d) Publish the List of congenital diseases recommended for prenatal and neonatal screening on the electronic information portal of the Vietnam Population Authority and the electronic information portal of the Ministry of Health.

2. The Administration of Maternal and Children’s Affairs shall cooperate with the Vietnam Population Authority, the Department of Medical Service Administration and relevant units in developing, updating and proposing competent authorities for issuance of technical procedures and guidelines on prenatal and neonatal screening, diagnosis and treatment in accordance with the Law on Medical Examination and Treatment.

3. The Department of Medical Service Administration shall cooperate with the Vietnam Population Authority, the Administration of Maternal and Children’s Affairs and relevant units in developing, updating and proposing competent authorities for issuance of technical procedures and guidelines on prenatal and neonatal screening, diagnosis and treatment in accordance with the Law on Medical Examination and Treatment.

4. Health authorities under province-level People’s Committees shall:

a) Take charge and organize the implementation of this Circular;

b) Within their authority, direct, or review and advise competent authorities on investing in facilities, equipment and human resource training for medical examination and treatment establishments under their management to ensure sufficient capacity for implementing prenatal and neonatal screening;

c) Disseminate information and promote communication so that the public understands and voluntarily participates in prenatal and neonatal screening for congenital diseases.

5. Medical examination and treatment establishments shall:

a) Provide counseling and screening for congenital diseases during the prenatal and neonatal stages in accordance with professional procedures issued by the Ministry of Health. The diagnosis and treatment of congenital diseases in the prenatal and neonatal stages comply with the Law on Medical Examination and Treatment;

b) Regional prenatal and neonatal screening and diagnostic centers shall perform assigned functions and tasks, and shall be responsible for relevant affairs in provinces and cities as assigned by the Minister of Health.

Authorities, organizations and individuals shall report any issues during the implementation to the Ministry of Health (Vietnam Population Authority) for guidelines and resolution./.

 

 

 

PP. MINISTER
DEPUTY MINISTER

Do Xuan Tuyen

 

APPENDIX I

THE LIST OF CONGENITAL DISEASES RECOMMENDED FOR PRENATAL SCREENING
(Attached to Circular No. 12 /2026/TT-BYT dated May 15, 2026 of the Minister of Health)

No.

ICD-10

Name of disease

Group I

Chromosomal and genetic disorders requiring routine prenatal screening

1

D56 Thalassaemia

2

Q90.0 Trisomy resulting from meiotic nondisjunction

3

Q91.0 Trisomy 18, meiotic nondisjunction

4

Q91.4 Trisomy 13, meiotic nondisjunction

5

Q96.0 Karyotype 45,X

6

Q98.0 Klinefelter syndrome karyotype 47,XXY

7

Q90-Q99 Chromosomal abnormalities (not elsewhere classified)

Group II

Structural fetal abnormalities requiring routine prenatal screening

8

Q00.0 Anencephaly

9

Q01 Encephalocele

10

Q03 Congenital hydrocephalus

11

Q04.2 Holoprosencephaly

12

Q05 Congenital spina bifida (split spine/cleft spine)

13

Q07.0 Arnold-Chiari syndrome

14

Q11.1 Other anophthalmos

15

Q20-Q28 Congenital malformations of the circulatory system

16

Q33.3 Agenesis of lung

17

Q35 Cleft palate

18

Q36 Cleft lip

19

Q37 Cleft palate with cleft lip

20

Q39 Congenital malformations of esophagus

21

Q41.0 Congenital absence, atresia, and/or stenosis of the duodenum

22

Q41.1 Congenital absence, atresia, and/or stenosis of the jejunum

23

Q60.1 Congenital bilateral renal agenesis

24

Q62.0 Congenital hydronephrosis

25

Q64.2 Congenital posterior urethral valve

26

Q66.0 Talipes equinovarus (Clubfoot)

27

Q69 Polydactyly

28

Q70 Syndactyly

29

Q71 Reduction defects of upper limb

30

Q72 Reduction defects of lower limb

31

Q74.3 Arthrogryposis multiplex congenita

32

Q75.0 Craniosynostosis

33

Q77.1 Thanatophoric short stature

34

Q77.4 Achondroplasia

35

Q78.0 Osteogenesis imperfecta

36

Q79.0 Congenital diaphragmatic hernia

37

Q79.2 Exomphalos

38

Q79.3 Gastroschisis
Group III Chromosomal and genetic disorders requiring prenatal screening in individuals with a personal or family history

39

D57 Sickle-cell disorders

40

D58 Other hereditary haemolytic anaemias

41

D66 Hereditary factor VIII deficiency

42

D67 Hereditary factor IX deficiency

43

E25.0 Congenital adrenogenital disorders associated with enzyme deficiency

44

E70.0 Classical phenylketonuria

45

E70.2 Disorders of tyrosine metabolism

46

E71.0 Maple-syrup-urine disease

47

E71.1 Other disorders of branched-chain amino-acid metabolism

48

E71.2 Disorder of branched-chain amino-acid metabolism, unspecified

49

E71.3 Disorders of fatty-acid metabolism

50

E72.1 Disorders of sulfur-bearing amino-acid metabolism

51

E72.2 Disorders of urea cycle metabolism

52

E72.3 Disorders of lysine and hydroxylysine metabolism

53

E72.4 Disorders of ornithine metabolism

54

E72.5 Disorders of glycine metabolism

55

E74.0 Glycogen storage disease

56

E74.2 Disorders of galactose metabolism

57

E74.4 Disorders of pyruvate metabolism and gluconeogenesis

58

E75.0 GM2 gangliosidosis

59

E75.2 Other sphingolipidosis

60

E76.0 Mucopolysaccharidosis, type I

61

E76.1 Mucopolysaccharidosis, type II

62

E84 Cystic fibrosis

63

G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]

64

G12.1 Other inherited spinal muscular atrophy

65

G71.0 Muscular dystrophy

66

Q61.2 Polycystic kidney, autosomal dominant

67

Q85.0 Neurofibromatosis (nonmalignant)

68

Q85.1 Tuberous sclerosis

69

Q87.4 Marfan syndrome

70

Q99.2 Fragile X chromosome

 

APPENDIX II

THE LIST OF CONGENITAL DISEASES RECOMMENDED FOR NEONATAL SCREENING
(Attached to Circular No. 12 /2026/TT-BYT dated May 15, 2026 of the Minister of Health)

A. Basic congenital disorders recommended for screening without the use of dried blood spots (DBS) on filter paper

No.

ICD 10 codes

Name of disease

1

H90

Conductive and sensorineural hearing loss

2

H91

Other hearing loss

3

Q20-Q28

Congenital malformations of the circulatory system

B. List of congenital disorders recommended for screening using dried blood spot (DBS) specimens on filter paper

No.

ICD 10 codes

Name of disease

I. Basic congenital disorders recommended for neonatal screening

1

E03.0 Congenital hypothyroidism with diffuse goitre

2

E03.1 Congenital hypothyroidism without goitre

3

E03.8 Other specified hypothyroidism

4

E25.0 Congenital adrenogenital disorders associated with enzyme deficiency

5

D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
II. Disorders of amino-acid metabolism

6

E70.0 Classical phenylketonuria

7

E70.1 Other hyperphenylalaninaemias

8

E71.0 Maple-syrup-urine disease

9

E70.2 Disorders of tyrosine metabolism

10

E72.1 Disorders of sulfur-bearing amino-acid metabolism
III. Disorders of organic-acid metabolism

11

E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

12

E71.1 Other disorders of branched-chain amino-acid metabolism

13

E72.3 Disorders of lysine and hydroxylysine metabolism

14

E53.8 Deficiency of other specified B group vitamins

15

E72.8 Other specified disorders of amino-acid metabolism
IV. Disorders of fatty-acid metabolism

16

E71.3 Disorders of fatty-acid metabolism
V. Disorders of urea cycle metabolism

17

E72.2 Disorders of urea cycle metabolism

18

E72.4 Disorders of ornithine metabolism
VI. Disorders of lysosomal storage

19

E74.0 Glycogen storage disease

20

E75.2 Other sphingolipidosis

21

E76.0 Mucopolysaccharidosis, type I

22

E76.1 Mucopolysaccharidosis, type II
VII. Other genetic diseases

23

E74.2 Disorders of galactose metabolism

24

G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]

25

G12.1 Other inherited spinal muscular atrophy

26

E84 Cystic fibrosis

27

D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis

28

D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

29

D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

30

D56 Thalassaemia

31

D57 Sickle-cell disorders

32

D58.2 Other haemoglobinopathies

33

G71.0 Muscular dystrophy

 

Thêm VnLawFirm trên Google
Chọn VnLawFirm làm nguồn ưu tiên trên Google Search. Xem hướng dẫn.

Diagram

Documents Referencing This (Inbound)

No documents referencing this.

Download Document

No attachment available.